Odonate Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2020	2019	2018	2017	2016	2015
Market Capitalization	67	631	896	347	354	640	640
Market Cap Growth	-	-29.61%	158.40%	-2.07%	-44.65%	0%	-
Enterprise Value	-23	479	718	208	156	637	640
PE Ratio	-1.15	-4.99	-8.25	-3.90	-10.82	-207.45	-4050.62
PB Ratio	0.94	4.63	5.52	2.80	1.81	280.33	5765.75
P/FCF Ratio	-1.17	-5.56	-9.26	-5.03	-13.66	-369.30	-3878.78
P/OCF Ratio	-1.17	-5.58	-9.28	-5.17	-13.70	-369.30	-3878.78
EV/EBITDA Ratio	-0.25	-3.77	-6.27	-2.30	-4.77	-206.61	-4049.75
EV/EBIT Ratio	-0.25	-3.76	-6.25	-2.29	-4.77	-	-
EV/FCF Ratio	-0.21	-4.22	-7.42	-3.01	-6.02	-367.80	-3877.94
Debt / Equity Ratio	0.07	0.04	0.01	0	0	0	0
Debt / EBITDA Ratio	-0.06	-0.04	-0.02	-	-	-	-
Debt / FCF Ratio	-0.05	-0.05	-0.02	-	-	-	-
Quick Ratio	3.14	5.81	7.28	7.64	26.37	4.35	4.76
Current Ratio	3.29	5.91	7.42	7.68	27.02	4.79	4.83
Return on Equity (ROE)	-157.61%	-92.81%	-66.99%	-71.74%	-16.71%	-135.13%	-142.34%
Return on Assets (ROA)	-106.35%	-75.26%	-57.58%	-62.35%	-16.09%	-107.08%	-112.86%
Return on Capital (ROIC)	-108.16%	-90.08%	-69.92%	-73.19%	-16.71%	-135.13%	-142.34%
Earnings Yield	-167.00%	-20.03%	-12.13%	-25.64%	-9.24%	-0.48%	-0.02%
FCF Yield	-140.41%	-18.00%	-10.80%	-19.89%	-7.32%	-0.27%	-0.03%
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.12%	0.00%
Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-25.64%	0.00%
Buyback Yield / Dilution	-15.55%	-18.96%	-12.12%	-73.87%	49.08%	-	-
Total Shareholder Return	-15.55%	-18.96%	-12.12%	-73.87%	49.08%	0.12%	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.